Gene therapy market isn’t just science fiction anymore—it’s transforming lives. In 2024, North America commanded an impressive 45% share of the global gene therapy market, and the momentum isn’t slowing down. What’s fueling this dominance?
✨ A surge in cancer and rare disease cases is pushing demand for advanced treatments. With governments stepping in with favorable funding and regulators greenlighting more gene therapy products, patients now enjoy greater access through improved insurance coverage and reimbursement programs.
💡 The region’s healthcare ecosystem is also seeing soaring R&D investments and rising healthcare spending, both of which are accelerating innovation in gene therapies.
Download Databook : https://www.towardshealthcare.com/download-databook/5804
🇺🇸 U.S. Gene Therapy Market – A Fight Against Cancer and Rare Diseases
The U.S. stands at the forefront of this revolution. Here’s why:
📈 Cancer remains a relentless adversary, ranking as the second leading cause of death overall and the #1 cause of death for Americans under 85. The numbers for 2025 are sobering—an expected 2.04 million new cancer cases and over 618,000 cancer-related deaths.
🧬 Adding to the urgency, rare diseases impact 25–30 million Americans, underscoring the need for breakthrough therapies. This massive patient population is driving unparalleled demand for gene therapies that offer hope where traditional treatments have fallen short.
🍁 Canada’s Gene Therapy Market – Robotics, AI, and Next-Gen Treatments
Canada isn’t sitting on the sidelines. The country is making bold moves to strengthen its biomanufacturing and life sciences industries.
🚀 In March 2025, the Canadian federal government unveiled support for innovative manufacturing of gene and cell therapies powered by robotics and AI. At the heart of this effort is Omnia Bio, spearheading projects aimed at treating chronic diseases like diabetes, cancer, autoimmune disorders, and neurological conditions.
This forward-thinking approach promises to make next-generation treatments safer, faster, and more accessible for Canadians.
🔮 The Takeaway
North America’s gene therapy market isn’t just growing—it’s redefining the future of medicine. From cutting-edge R&D to government-backed innovation, the region is paving the way for a new era in healthcare.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
The global proteinase K market biotech industry is rapidly evolving, driven by major investments in research and development across key… Read More
The global epigenetic antibodies market is witnessing exponential growth. Valued at USD 2.29 billion in 2024, the market is forecast… Read More
The global molecular spectroscopy market is witnessing rapid growth, driven by advancements in healthcare, pharmaceuticals, and environmental testing. Cutting-edge technologies,… Read More
The global DNA polymerase market is witnessing remarkable growth, driven by expanding applications in diagnostics, genetic research, forensics, and industrial… Read More
The global hematology analyzers market is witnessing steady growth and innovation, driven by the increasing incidence of blood-related disorders such… Read More
In 2024, the global artificial lung market stood at USD 2.51 billion. One year later, it is estimated to grow… Read More